Home Health FDA approves $3.5 million treatment for hemophilia, now the most expensive drug...

FDA approves $3.5 million treatment for hemophilia, now the most expensive drug in the world | CNN





CNN
 — 

The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug in the world.

Hemgenix is a gene therapy to treat adults with hemophilia B, a genetic bleeding disorder in which people do not produce a protein needed to create blood clots. About 1 in 40,000 people have the disease, most of whom are men.

Typical treatment requires routine intravenous infusions to maintain sufficient levels of the missing or deficient clotting factor, but the new gene therapy is meant to be a one-time IV infusion.

“Gene therapy for hemophilia has been on the horizon for more than two decades. Despite advancements in the treatment of hemophilia, the prevention and treatment of bleeding episodes can adversely impact individuals’ quality of life,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement. “Today’s approval provides a new treatment option for patients with Hemophilia B and represents important progress in the development of innovative therapies for those experiencing a high burden of disease associated with this form of hemophilia.”

The Institute for Clinical and Economic Review, an independent nonprofit research organization that analyzes the value of prescription drugs and other medical products, confirmed for CNN that Hemgenix is now the most expensive drug in the world.

In a recent cost-effectiveness analysis of the drug, weighing health benefits against offset costs, ICER suggested that a fair price for the drug to be between $2.93 million and $2.96 million.

According to an analysis by GoodRx, the most expensive drug in the US previously was Zolgensma, which was approved by the FDA in 2019 to treat spinal muscular atrophy and priced at $2.1 million for a course of treatment.

FDA approved Hemgenix based on safety and effectiveness evaluated in two studies of about 60 adult men. The most common side effects included high liver enzymes, headaches, flu-like symptoms and mild infusion-related reactions.



Source link

RELATED ARTICLES

Matt Hancock accused of rewriting history in pandemic book

Matt Hancock has been accused of rewriting history as he seeks to rescue his reputation with the launch of a book about helping...

IISc PhD student wins award in Berlin for device to detect drug-resistant tuberculosis

Indian Institute of Science, Bengaluru. | Photo Credit: SUDHAKARA JAIN A PhD student of Indian Institute of Science, representing India, has been awarded the third...

Strep A: No 10 warns parents to look out for signs of infection

Downing Street has warned parents to be on the lookout for signs of strep A infection as a senior health official said the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Metaverse comes in second place for Oxford’s word of the year

The Oxford University Press team chose 'metaverse’ to come in as a runner-up to ‘Goblin mode’ for the word of the year in...

Matt Hancock accused of rewriting history in pandemic book

Matt Hancock has been accused of rewriting history as he seeks to rescue his reputation with the launch of a book about helping...

The Super Mario Bros. Movie actually looks awesome | Digital Trends

The latest trailer for The Super Mario Bros. Movie has reignited hype for the animated blockbuster and then some. Featuring a plethora of...

Justin Verlander, Mets agree to two-year, $86 million deal: report

The New York Mets have reportedly reached a deal with AL Cy Young Award winner Justin Verlander. Days after reportedly meeting with the team...

Recent Comments